Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.036 | 0.9 |
mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.9 |
mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |